Pemigatinib
Brand name: Pemazyre
Pemigatinib comes in 6 pill versions in our database, in 3 strengths, from 1 manufacturer. Check the imprint to tell them apart.
Pemigatinib pill images
4.5 mg 2 pills
- I 45 Pemigatinib 4.5 mg White, round, 6 mm Used for cholangiocarcinoma
- I 4.5 Pemigatinib 4.5 mg White, round Used for cholangiocarcinoma
9 mg 2 pills
- I 9 Pemigatinib 9 mg White, oval, 10 mm Used for cholangiocarcinoma
- I 9 Pemigatinib 9 mg White, oval Used for cholangiocarcinoma
13.5 mg 2 pills
What is Pemigatinib used for?
Pemigatinib is used for cholangiocarcinoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Cholangiocarcinoma
PEMAZYRE is indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.
This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
PEMAZYRE is indicated for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with fibroblast growth factor receptor 1 (FGFR1) rearrangement.
From the FDA-approved label on DailyMed (published Jun 15, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.